Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
Objective. Women who develop GDM present a metabolic condition similar to that found in type 2 diabetes, characterized by impaired insulin response. Due to similar pathophysiologic mechanisms found between type 2DM and GDM, there is a great interest in finding markers that will lead to the understan...
Saved in:
| Main Authors: | Katarzyna Gawlik, Tomasz Milewicz, Dorota Pawlica-Gosiewska, Iwona Trznadel-Morawska, Bogdan Solnica |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2023/4024877 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating fibroblast growth factor 21 levels in gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis
by: Zhen Cao, et al.
Published: (2025-01-01) -
Prevention of gestational diabetes mellitus
by: N. V. Artymuk, et al.
Published: (2023-09-01) -
Postpartum Type 2 Diabetes Mellitus Frequency of Patients with Gestational Diabetes Mellitus
by: Lezzan Keskin
Published: (2023-10-01) -
Fibroblast Growth Factor 21 Levels Are Associated With Perception and Neural Responses to Sweetness in Type 2 Diabetes Mellitus
by: Piao Kang, et al.
Published: (2025-07-01) -
Effect of Gestational Diabetes Mellitus on the Growth, Development, and Stem Cells of Offspring
by: Meihua Zhang, et al.
Published: (2023-01-01)